About Chance Pharmaceuticals
Chance Pharmaceuticals is a company based in Hangzhou (China) founded in 2015 by Peng Huang, Guobao Zhao, Donghao Chen, and Lan Chen.. Chance Pharmaceuticals has raised $31.03 million across 3 funding rounds from investors including Geintech Technologies, Qihang Capital and Fortune Capital. Chance Pharmaceuticals operates in a competitive market with competitors including MediciNova, TFF Pharmaceuticals, Theravance Biopharma, Elastrin and ReAlta Life Sciences, among others.
- Headquarter Hangzhou, China
- Founders Peng Huang, Guobao Zhao, Donghao Chen, Lan Chen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$31.03 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
Geintech Technologies
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chance Pharmaceuticals
Chance Pharmaceuticals has successfully raised a total of $31.03M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(11 Oct 2021)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series C - Chance Pharmaceuticals | Valuation |
investors |
|
| Jan, 2022 | Amount | Series C - Chance Pharmaceuticals | Valuation |
investors |
|
| Oct, 2021 | Amount | Series C - Chance Pharmaceuticals | Valuation | Long Rock Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Chance Pharmaceuticals
Chance Pharmaceuticals has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Geintech Technologies, Qihang Capital and Fortune Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Geintech Technologies is engaged in manufacturing high-standard communication cables.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Chance Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Chance Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chance Pharmaceuticals Comparisons
Competitors of Chance Pharmaceuticals
Chance Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediciNova, TFF Pharmaceuticals, Theravance Biopharma, Elastrin and ReAlta Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small-molecule therapeutics are developed for asthma, COPD, and neurologic diseases.
|
|
| domain | founded_year | HQ Location |
Developer of inhalation products for chronic respiratory diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory and immunological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic targets related to arterial and lung diseases
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs for acute inflammatory and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Chance Pharmaceuticals
Frequently Asked Questions about Chance Pharmaceuticals
When was Chance Pharmaceuticals founded?
Chance Pharmaceuticals was founded in 2015 and raised its 1st funding round 6 years after it was founded.
Where is Chance Pharmaceuticals located?
Chance Pharmaceuticals is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.
Who is the current CEO of Chance Pharmaceuticals?
Donghao Chen is the current CEO of Chance Pharmaceuticals. They have also founded this company.
Is Chance Pharmaceuticals a funded company?
Chance Pharmaceuticals is a funded company, having raised a total of $31.03M across 3 funding rounds to date. The company's 1st funding round was a Series C of $31.03M, raised on Oct 11, 2021.
What does Chance Pharmaceuticals do?
Chance Pharmaceuticals was founded in 2015 in Hangzhou, China, within the pharmaceuticals sector. Focus is placed on inhalation therapies targeting pulmonology disorders. The lead candidate, CXF11, a tiotropium bromide inhalation drug, is developed for preventing bronchospasm in chronic obstructive pulmonary disease patients. An inhaler for dispersing powder and delivering particles to the lung is also under development. Operations center on drug and device innovation for respiratory conditions.
Who are the top competitors of Chance Pharmaceuticals?
Chance Pharmaceuticals's top competitors include TFF Pharmaceuticals, Theravance Biopharma and MediciNova.
Who are Chance Pharmaceuticals's investors?
Chance Pharmaceuticals has 7 investors. Key investors include Geintech Technologies, Qihang Capital, Fortune Capital, CMS China, and Heda Capital.